80 related articles for article (PubMed ID: 11035438)
21. Inhibition of Fas/Fas ligand-mediated apoptotic cell death of lymphocytes in vitro by circulating anti-Fas ligand autoantibodies in patients with systemic lupus erythematosus.
Suzuki N; Ichino M; Mihara S; Kaneko S; Sakane T
Arthritis Rheum; 1998 Feb; 41(2):344-53. PubMed ID: 9485093
[TBL] [Abstract][Full Text] [Related]
22. Increased CD38 expression in T cells and circulating anti-CD38 IgG autoantibodies differentially correlate with distinct cytokine profiles and disease activity in systemic lupus erythematosus patients.
Pavón EJ; Zumaquero E; Rosal-Vela A; Khoo KM; Cerezo-Wallis D; García-Rodríguez S; Carrascal M; Abian J; Graeff R; Callejas-Rubio JL; Ortego-Centeno N; Malavasi F; Zubiaur M; Sancho J
Cytokine; 2013 May; 62(2):232-43. PubMed ID: 23538292
[TBL] [Abstract][Full Text] [Related]
23. Characterization of autoantibody activities in sera anti-DNA antibody and circulating immune complexes from 12 systemic lupus erythematosus patients.
Adyel FZ; Hentati B; Boulila A; Hachicha J; Ternynck T; Avrameas S; Ayadi H
J Clin Lab Anal; 1996; 10(6):451-7. PubMed ID: 8951619
[TBL] [Abstract][Full Text] [Related]
24. The lupus band: do the autoantibodies target collagen VII?
Alahlafi AM; Wordsworth P; Wojnarowska F
Br J Dermatol; 2004 Mar; 150(3):504-10. PubMed ID: 15030334
[TBL] [Abstract][Full Text] [Related]
25. Immune tolerance to autoantibody-derived peptides delays development of autoimmunity in murine lupus.
Singh RR; Ebling FM; Sercarz EE; Hahn BH
J Clin Invest; 1995 Dec; 96(6):2990-6. PubMed ID: 8675671
[TBL] [Abstract][Full Text] [Related]
26. Nature of IgG anti-lymphocyte autoantibody-reactive molecules shed from activated T cells in systemic lupus erythematosus.
Minota S; Winfield JB
Rheumatol Int; 1988; 8(4):165-70. PubMed ID: 3055216
[TBL] [Abstract][Full Text] [Related]
27. Altered glycosylation of complexed native IgG molecules is associated with disease activity of systemic lupus erythematosus.
Sjöwall C; Zapf J; von Löhneysen S; Magorivska I; Biermann M; Janko C; Winkler S; Bilyy R; Schett G; Herrmann M; Muñoz LE
Lupus; 2015 May; 24(6):569-81. PubMed ID: 25389233
[TBL] [Abstract][Full Text] [Related]
28. Nucleosomes are major T and B cell autoantigens in systemic lupus erythematosus.
Bruns A; Bläss S; Hausdorf G; Burmester GR; Hiepe F
Arthritis Rheum; 2000 Oct; 43(10):2307-15. PubMed ID: 11037891
[TBL] [Abstract][Full Text] [Related]
29. Rabbit anti-HMG-17 antibodies recognize similar epitopes on the HMG-17 molecule as lupus autoantibodies. Relation with histone H1 defined epitopes.
Boumba VA; Seferiadis K
J Pept Sci; 2002 Dec; 8(12):683-94. PubMed ID: 12523645
[TBL] [Abstract][Full Text] [Related]
30. High prevalence of autoantibodies against the nuclear high mobility group (HMG) protein SSRP1 in sera from patients with systemic lupus erythematosus, but not other rheumatic diseases.
Santoro P; De Andrea M; Migliaretti G; Trapani C; Landolfo S; Gariglio M
J Rheumatol; 2002 Jan; 29(1):90-3. PubMed ID: 11824977
[TBL] [Abstract][Full Text] [Related]
31. Expression and function of inducible co-stimulator in patients with systemic lupus erythematosus: possible involvement in excessive interferon-gamma and anti-double-stranded DNA antibody production.
Kawamoto M; Harigai M; Hara M; Kawaguchi Y; Tezuka K; Tanaka M; Sugiura T; Katsumata Y; Fukasawa C; Ichida H; Higami S; Kamatani N
Arthritis Res Ther; 2006; 8(3):R62. PubMed ID: 16563187
[TBL] [Abstract][Full Text] [Related]
32. Increased expression and release of functional tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) by T cells from lupus patients with active disease.
Rus V; Zernetkina V; Puliaev R; Cudrici C; Mathai S; Via CS
Clin Immunol; 2005 Oct; 117(1):48-56. PubMed ID: 15961346
[TBL] [Abstract][Full Text] [Related]
33. CD45 isoforms expression on CD4+ and CD8+ peripheral blood T-lymphocytes is related to auto-immune processes and hematological manifestations in systemic lupus erythematosus.
Neidhart M; Pataki F; Michel BA; Fehr K
Schweiz Med Wochenschr; 1996 Nov; 126(45):1922-5. PubMed ID: 8946597
[TBL] [Abstract][Full Text] [Related]
34. Evidence for an association of CD45 with 32,000-33,000 MW phosphoproteins on murine T and B lymphocytes.
Altin JG; Pagler EB; Parish CR
Immunology; 1994 Nov; 83(3):420-9. PubMed ID: 7835967
[TBL] [Abstract][Full Text] [Related]
35. Opsonization of late apoptotic cells by systemic lupus erythematosus autoantibodies inhibits their uptake via an Fcgamma receptor-dependent mechanism.
Reefman E; Horst G; Nijk MT; Limburg PC; Kallenberg CG; Bijl M
Arthritis Rheum; 2007 Oct; 56(10):3399-411. PubMed ID: 17907194
[TBL] [Abstract][Full Text] [Related]
36. Targeting human immunodeficiency virus type 1 with antibodies derived from patients with connective tissue disease.
Scherl M; Posch U; Obermoser G; Ammann C; Sepp N; Ulmer H; Dierich MP; Stoiber H; Falkensammer B
Lupus; 2006; 15(12):865-72. PubMed ID: 17211992
[TBL] [Abstract][Full Text] [Related]
37. The mechanism of nasal tolerance in lupus prone mice is T-cell anergy induced by immature B cells that lack B7 expression.
Wu HY; Monsonego A; Weiner HL
J Autoimmun; 2006 Mar; 26(2):116-26. PubMed ID: 16426816
[TBL] [Abstract][Full Text] [Related]
38. CD45 ligation induces programmed cell death in T and B lymphocytes.
Klaus SJ; Sidorenko SP; Clark EA
J Immunol; 1996 Apr; 156(8):2743-53. PubMed ID: 8609392
[TBL] [Abstract][Full Text] [Related]
39. Autoantibodies against the replication protein A complex in systemic lupus erythematosus and other autoimmune diseases.
Yamasaki Y; Narain S; Hernandez L; Barker T; Ikeda K; Segal MS; Richards HB; Chan EK; Reeves WH; Satoh M
Arthritis Res Ther; 2006; 8(4):R111. PubMed ID: 16846524
[TBL] [Abstract][Full Text] [Related]
40. Autoantibodies against complement receptor 1 (CD35) in SLE, liver cirrhosis and HIV-infected patients.
Sadallah S; Hess C; Trendelenburg M; Vedeler C; Lopez-Trascasa M; Schifferli JA
Clin Exp Immunol; 2003 Jan; 131(1):174-81. PubMed ID: 12519402
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
